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Cistanche species, known as Rou Cong-Rong in Chinese, are an endangered
wild species and are mainly distributed in the arid lands and warm deserts of
northwestern China. Within Traditional Chinese Medicine (TCM), Herba Cistanche
is applied as a tonic and/or in a formula for chronic renal disease, impotence,
female infertility, morbid leucorrhea, profuse metrorrhagia, and senile constipation.
The chemical constituents of Herba Cistanche mainly consist of volatile oils, non-
volatile phenylethanoid glycosides (PhGs), iridoids, lignans, alditols, oligosaccharides,
and polysaccharides. There have been an increasing number of studies focusing on
its bio-activities, including antioxidation, neuroprotection, and antiaging. The objective
of this review is to introduce this herb to the world. Its taxonomy, distribution, and
corresponding biological functions and molecular mechanisms are addressed in this
review.
Keywords: Cistanche species, Herba Cistanche, phenylethanoid glycosides, improvement of brain function,
aphrodisiac effect, immune-boosting effect
Cistanche Hoffmg. Et Link is a genus within the Orobanchaceae family and includes 22 species
throughout the world. The cistanche species include the perennial parasite herbs, which commonly
attach onto the roots of sand-fixing plants, such as Haloxylon ammodendron, H. persicum,
Kalidium foliatum, and Tamarix plants (Li et al., 2013b). Generally, cistanche species distribute
in arid lands and deserts in the northern hemisphere, such as the provinces of Xinjiang, Inner
Mongolia, Gansu, Qinghai, and the Ningxia Autonomous Region in China in addition to similar
regions of countries such as Iran, India, and Mongolia (Jiang and Tu, 2009). The growth and
cultivation of cistanche species require severe environmental conditions: extreme arid climate,
depauperate soils, large temperature difference, intensive sunshine, and less than 250 mm of annual
precipitation (Qiao et al., 2007). Among the 22 species in the world, six are found in China
according to the Taxonomical Index of Chinese Higher Plants (Plant Institute of Chinese Academy
of Science, 1994); however, a follow-up study indicated that only 4 species and 1 variation of
cistanche exist in China, including Cistanche deserticola Y. C. Ma, C. tubulosa (Schenk) R. Wight,
C. salsa (C. A. Mey.) G. Beck, C. salsa var. albiflora P. F. Tu et Z. C. Lou and C. sinensis G. Beck
(Jiang and Tu, 2009).
The Herba Cistanche (Rou Cong-Rong in Chinese) was first recorded in Shen Nong’s Chinese
Materia Medica, where it was referred to as the dried succulent stems of the cistanche species
(Karalliedde and Kappagoda, 2009). Among all the tonics in traditional Chinese medicine (TCM),
Herba Cistanche is widely accepted as a superior one and has even been given the name “Ginseng
of the deserts.” In TCM, Herba Cistanche is frequently prescribed to treat chronic renal disease,
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FIGURE 1 | Timeline of Herba Cistanche records in the traditional Chinese herb classic texts. The uses of Herba Cistanche have evolved over nearly
2,000 years. Herba Cistanche was described in the oldest surviving herb classic, Shennong Bencao Jing (approximately 100 A.D.). Since then, it has been
described in many famous traditional Chinese herb classics spanning different dynasties, including Yaoxinglun, The Compendium of Materia Medica
(Bencaogangmu), and Benjingfengyuan. It was the most frequently prescribed drug against chronic renal disease in China for successive dynasties. In 2000 and
2005, C. deserticola was reordered in the Chinese Pharmacopoeia (2000), and C. tubulosa was added to the Chinese Pharmacopoeia (2005) as an alternative.
Products manufactured in China that are made from Herba Cistanche (e.g., its extracts) or that include the herb (e.g., prepared formulas) are not restricted.
impotence, female infertility, morbid leucorrhea, profuse
metrorrhagia, and senile constipation (Zhang et al., 2005). In
2000 and 2005, respectively, C. tubulosa, and C. deserticola
were indexed in the Chinese Pharmacopeia (Pharmacopoeia,
2000) (Figure 1). C. tubulosa is offered as an alternative for
C. deserticola because of its similar chemical constituents and
pharmacological activities and its abundance (Pharmacopoeia,
2005). Other species of this genus, e.g., C. salsa and C. sinensis, are
also used as alternatives in some areas. Cistanche is considered
a new cultivated plant in several regions in northwestern China,
where the rainfall is low and soil desertification is severe.
Since the 1980s, researchers have been interested in Herba
Cistanche. A chemical analysis of Herba Cistanche revealed that
essential oils, phenylethanoid glycosides (PhGs), iridoids, lignans,
alditols, oligosaccharides, cistanosides, and polysaccharides
were the main constituents (Jin and Zhang, 1994). Herba
Cistanche extracts are pharmacologically active, with a range
of functions that include improving chronic renal disease
and senile constipation, increasing learning/memorizing ability,
treating Alzheimer’s disease (AD), and improving immunity
(Snytnikova et al., 2012; Zhang et al., 2012; Guo et al.,
2013; Li et al., 2013a; Nan et al., 2013). Most pharmaceutical
companies are hoping to find the next ‘miracle’ drug, such as
artemisinin (qinghaosu), an antimalarial drug that is extracted
from the medicinal plant sweet wormwood and has saved
millions of lives. The other classic example of a modern
medicine that originated in TCM is arsenic trioxide, which
was approved by the US Food and Drug Administration
(FDA) to treat leukemia in 2000. The present overview focuses
on the progress of the study of chemical constituents of
Herba Cistanche and some of its relevant pharmacological
activities.
CHEMICAL CONSTITUENTS
Volatile Compounds
In essential oil of the Herba Cistanche, alkanes, alcohols,
aldehydes, and heterocyclics were detected, and palmitic acid,
linoleic acid, 14-methylpentadecanoate, ethyl palmitate, and
2,5,6-trimethyloctane were identified. The total oils of C. tubulosa
mainly consist of palmitic acid and linoleic acid, while the
essential oil of C. salsa includes alkanes, alcohols, aldehydes,
and some heterocyclic compounds (Jiang and Tu, 2009). The
volatile compounds of Herba Cistanche, like the essential oils,
commonly can be extracted by steam distillation or lipophilic
organic solvent. By extracting C. deserticola with petroleum
ether and then analyzing the sample on a GC-MS, 25 volatile
compounds were identified, and the 3 richest constituents in
the petroleum ether extract are methyl 14-methylpentadecanoate
(13.61%), ethyl palmitate (12.39%), and 2,5,6-trimethyloctane
(7.60%) (Jiang and Tu, 2009).
Non-Volatile Compounds
Among the non-volatile compounds of Herba Cistanche,
more than 100 have currently been isolated and identified.
These compounds are mostly PhGs, iridoids, lignans, alditols,
oligosaccharides, and polysaccharides. As an important class
of the compounds that constitute Herba Cistanche, PhGs have
been well studied (Table 1). To date, 34 PhG compounds
have been successfully isolated from Herba Cistanche, including
22 disaccharide glycosides, 10 trisaccharide glycosides, and 2
monosaccharide glycosides. The empirical structural features of
PhGs are as follows. (1) For disaccharide glycosides, the sugar
moiety consists of glucose and rhamnose connected by a Glc
(3 → 1) Rha linkage; the glucose commonly links directly to
an aglycone, and a coumaroyl or caffeoyl is usually located
at the C4 or C6 position. (2) For trisaccharide glycosides,
there is another glucose or rhamnose at the C6 position of
the inside glucose. Recently, Li et al. (2015) completed the
first deep transcriptome sequencing of the fleshy stem of C.
deserticola by RNA-seq and identified some key enzyme genes
and pathways that are involved in the biosynthesis of lignin
and PhGs, which provides valuable information for this medical
plant.
For the other non-volatile compounds of Herba Cistanche, 3
iridoid aglycones and 14 iridoid glycosides have currently been
isolated from cistanche species (Xie et al., 2006); 1 and 5 lignan
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glycosides have been isolated from C. deserticola and C. tubulosa,
respectively. Only 2 alkaloids, betaine and N,N-dimethyl glycine
methyl ester, have been isolated from Herba Cistanche (Jiang and
Tu, 2009). Small amounts of other compounds, such as phenolic
glycosides, sterols or their glycosides, fatty acids, amino acids, and
trace elements, are also present in Herba Cistanche (Snytnikova
et al., 2012).
PHARMACOLOGICAL ACTIVITIES
Based on the neuroprotection, immune-enhancement, and sexual
health properties of Herba Cistanche, we had a discussion in the
paper (Supplementary Figure S1).
Improvement of Brain Function
When considering learning and memory, three levels of
mechanisms are involved: (1) the ability to acquire memory,
i.e., learning ability; (2) the ability to store memory, i.e.,
consolidation; and (3) the ability to recall memorized
information (Choi et al., 2011). The C. tubulosa extract was
confirmed to significantly improve these mechanisms by
preventing brain neuron apoptosis through the expression
of apoptosis-related factors and neurotrophic factors
in MES23.5 cells (Lin et al., 2013). C. tubulosa extract,
containing rich echinacoside, and acteoside, can alleviate
the cognitive dysfunction caused by Aβ1−42 through blocking
amyloid deposition, reversing cholinergic, and hippocampal
dopaminergic neuronal function in AD-like rat model (Wu
et al., 2014). One of the PhGs, echinacoside, is typically known
as the main phenolic component in the roots of Echinacea
angustifolia, which is widely used in Europe and North America
for its immunoregulation properties. A recent study determined
that echinacoside can rescue human fibroblasts (SHSY5Y)
from TNFα-induced apoptosis. The results indicated that
echinacoside protects the damaged fibroblasts by regulating the
reactive oxygen species level in fibroblasts and the activation of
caspase-3 (Zhao et al., 2010). In vitro and in vivo experiments
have confirmed that individual PhGs can inhibit the apoptosis
of neuronal cells induced by various chemicals (Tian and Pu,
2005; Geng et al., 2007). Therefore, the individual PhGs could
be attractive candidates against some typical neurodegenerative
disorders, such as dementia or Parkinson’s disease (PD).
Moreover, an open-label, non-placebo-controlled study on
C. tubulosa glycoside capsules (Memoregain R©) demonstrates that
the drug has a potential to be a possible treatment option for
mild to moderate AD, and all adverse reactions were mild. (Guo
et al., 2013).
Similarly, the C. salsa extract can accelerate the proliferation
of fibroblasts and promote the production of neurons by
accelerating the growth of the neurites. It also has some properties
as follows: prevent damage caused by cerebral ischemia-
reperfusion; protect against apoptosis of the CA1 region of
hippocampus (Wang et al., 2004); and increase the amount
of neurotransmitters, such as dopamine (DA), noradrenaline
(NA), and serotonin (5-HT), in the rat brain (Chen et al.,
2007; Choi et al., 2011; Zhong et al., 2012). The acteoside-
rich fraction of C. salsa extract can inhibit reactive oxygen
species, prevent DNA damage, enhance superoxide dismutase
(SOD) activity and prevent lipid peroxidation (Lin et al., 2002;
Deng et al., 2004b; He et al., 2009a). Because acteoside has an
extremely strong antioxidative effect that is 15 times stronger
than resveratrol and five times stronger than vitamin C (Chiou
et al., 2004).
Aphrodisiac Effect
A recent study has demonstrated that an ethanol extract of
C. tubulosa could increase the sex hormone levels by inducing
testicular steroidogenic enzymes (e.g., CYP11A1, CYP17A1,
CYP3A4) (Wang et al., 2015). Besides, the gene expression
of 3β-hydroxysteroid dehydrogenase (3β-HSD), which is
responsible for the synthesis of testosterone, 5α-reductase-2
and aldo-keto reductase (enzymes that are responsible for
the synthesis of dihydrotestosterone), can be induced by the
C. tubulosa extract, suggesting the positive effect of C. tubulosa
extract on male hormone production (Shimoda et al., 2009).
The acteoside, which was distilled from C. tubulosa, significantly
shortened the latent period of penis erection (p< 0.01), increased
the number of germ cells (p < 0.01), and improved pathological
changes in the testes (Ma et al., 2009). Echinacoside, which is
another newly identified PhG and is typically known as the
main component of echinacea, is abundant in C. tubulosa
and possesses vaso-relaxing activity (Yoshikawa et al., 2006).
The aphrodisiac mechanisms of C. tubulosa might involve
the NO-cGMP signal transduction pathway, with increasing
cGMP levels in the corpus cavernosum smooth muscle (He
et al., 2009b). Pan and Min (2004) indicated that the combined
use of Herba Cistanche extract could prevent adrenal cortical
atrophy, which is typically caused by using corticosteroids only.
Moreover, C. deserticola extract could reverse the reproductive
toxicity in mice induced by hydroxyurea (Gu et al., 2013) and
glycoside of Leigongteng (Radix et Rhizoma Tripterygii) (Li et al.,
2014).
According to TCM, Yang-Qi Kidney-Yang Deficiency
Syndrome (KDS-Yang) is caused by insufficient “Yang-Qi” in
the kidney. Briefly, Yang-Qi is a TCM term and likely indicates
mitochondrion-driven biological activities of the human body
in the view of biomedical research (Leong et al., 2015). In H9c2
cardiomyocytes, Herba Cistanche was proven to enhance the
mitochondrial respiration and glutathione antioxidant status
(Wong and Ko, 2013). Yang-Qi deficiencies in TCM resemble
those of chronic fatigue syndrome in Western medicine.
KDS-Yang symptoms include soreness and weakness of the
waist and knees, cold chills, deafness, and tinnitus. Modern
studies showed that damage and functional disorders of the
hypothalamic-pituitary-target gland axis, including the adrenal
gland, thyroid, and gonad, are the main pathological mechanisms
of KDS-Yang (Zhao et al., 2013). Gong et al. (2008) investigated
the intervention effect of C. deserticola (decoction, 10 g/kg·d) in
hydrocortisone-induced KDS-Yang model rats and found that
C. deserticola extract could increase body weight, autonomic
activity, and swimming time while decreasing post-exercise
blood lactic acid (LAC) and blood urea nitrogen (BUN). As
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described in the Compendium of Materia Medica, Herba
Cistanche is mild and would not be extremely abrupt or harsh
when treating KDS-Yang. Interestingly, KDS-Yang also leads to
low and disordered immune function, and thus, there is a close
relationship between treating KDS-Yang and improving immune
function (Yim and Ko, 2002).
Immune-Boosting Effect
Besides its traditional use, the daily consumption of Herba
Cistanche is believed to the key of the people with longevity in
some region of China and Japan where known for longevity and
oasis. Studies shown that both C. salsa extract and C. tubulosa
extract can activate lymphoid cells and increase the killed rate
of cancer cells (Maruyama et al., 2009). C. deserticola extract
can activate the phagocytic function of macrophages in mice
and enhance body immunity (Li et al., 2009). Carbohydrates
account for a high proportion of the dry mass of Herba
Cistanche. The polysaccharides of C. deserticola are closely
related to the immunity enhancing and anti-cancer functions (Xu
et al., 2011). Galactitol is one of the monosaccharides in Herba
Cistanche with laxative activity (Baishun et al., 2003). Individual
compounds such as oligosaccharides present an excellent effect
on the spleen activity of mice, increase the phagocytotic
activity of macrophages and stimulate the proliferation of
antibody-producing cells (Maruyama et al., 2008). Acteoside
(10 or 50 mg/kg subcutaneously) significantly inhibits hepatic
apoptosis, hepatitis and lethality in mice with hepatic apoptosis
and liver failure were induced by D-galactosamine (DGalN)
and lipopolysaccharide (LPS) (Xiong et al., 1999). Echinacoside-
enriched extract of C. tubulosa is effective in preventing dextran
sulphate sodium (DSS)-induced colitis in mice (Jia et al., 2014).
Recently, Zhang et al. (2014) discovered that C. deserticola extract
could antagonize immune-related senescence and extend the
lifespan in SAM-P8 mice. In Zhang’s et al. (2014) study, dietary
supplementation with C. deserticola extract can decrease the level
of peripheral memory T cells and enhance levels of naive T
cells. Additionally, Herba Cistanche aqueous extract was proven
to prevent bone loss caused by ovarian hormone deficiency
through regulating some bone metabolism related genes (e.g.,
Smad1, Smad5, TGF-b1, and TIEG1) (Liang et al., 2011, 2013),
and amonoterpene from C. salsa has been identified as an
anti-osteoporotic compound (Yamaguchi et al., 1999). Herba
Cistanche helps people better understand the synergistic effect
mechanisms of the effective components in TCM.
CONCLUSION
Herba Cistanche has been commonly used traditionally
for enhancing immunity, sexual health, antioxidation, and
neuroprotection, and tonic. Various Herba Cistanche products
and its derivative are widely used in modern China. The uses of
this drug have evolved over nearly 2,000 years, and the demand
for Herba Cistanche has grown rapidly in recent years. After a
long-term use, those compounds with proven pharmacological
activity, such as acteoside, and echinacoside, deserve more in-
depth study before they truly could improve patient quality of
life. With further study, this important TCM is believed to have
profound prospects.
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FIGURE S1 | Main biological functions and mechanisms of the active
components of Herba Cistanche. The active ingredients isolated from Herba
Cistanche have three main biological functions: improvement of brain function,
immune-boosting effect, and nourishing aphrodisiac effect. Herba Cistanche
extracts are mixtures of multiple active compounds, and a typical traditional
Chinese medicine (TCM) recognizes multiple biological targets. Phenylethanoid
glycosides (PhGs) have neuroprotective properties in neurodegenerative disease
based on their free radical scavenging ability, anti-apoptosis activity,
anti-inflammation activity, the increasing amount of brain neurotransmitters and
enhanced SOD activity. A modern use of Herba Cistanche in Chinese herbalism
is to treat KDS-Yang, which contributes to fertility problems (including impotence
and female infertility) because Herba Cistanche is different from other herbs that
often have a more vigorous action. Herba Cistanche regulates the
hypothalamic-pituitary-gonad (HPG) and hypothalamic-pituitary-adrenal (PHA)
axes, which may induce a smooth and balanced sexual vitality effect. Moreover,
phenylethanoid oligoglycosides and acylated oligosaccharides from Herba
Cistanche have vasorelaxant activity via the NO-cGMP pathway. Based on
clinical and experimental data, activation of the HPA axis increases plasma
cytokines and acute phase protein concentrations. Thus, it can increase
phytohemagglutinin-stimulated lymphocyte proliferation and enhance antibody
production in response to T-dependent antigens in spleen cells.
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